Nobuhiko Fukuda

Yokohama, 2360004, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.

The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications.

Journal: Genes
Published: August 22, 2025

Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study.

Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study.

Journal: Translational lung cancer research
Published: February 13, 2025

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Translational lung cancer research
Published: January 30, 2025

The Impact of Bevacizumab and miR200c on EMT and EGFR-TKI Resistance in EGFR-Mutant Lung Cancer Organoids.

The Impact of Bevacizumab and miR200c on EMT and EGFR-TKI Resistance in EGFR-Mutant Lung Cancer Organoids.

Journal: Genes
Published: August 29, 2024

Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Journal: Thoracic cancer
Published: February 02, 2024

Geographic and economic influences on benralizumab prescribing for severe asthma in Japan.

Geographic and economic influences on benralizumab prescribing for severe asthma in Japan.

Journal: Scientific reports
Published: November 27, 2023

Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes.

Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes.

Journal: Cancers
Published: September 24, 2023

Compartmentalized mitochondrial ferroptosis converges with optineurin-mediated mitophagy to impact airway epithelial cell phenotypes and asthma outcomes.

Compartmentalized mitochondrial ferroptosis converges with optineurin-mediated mitophagy to impact airway epithelial cell phenotypes and asthma outcomes.

Journal: Nature communications
Published: July 11, 2023

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.

Journal: The Cochrane database of systematic reviews
Published: June 05, 2023

Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.

Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.

Journal: Therapeutic advances in medical oncology
Published: April 04, 2023

Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis.

Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis.

Journal: The Journal of infectious diseases
Published: March 27, 2023

Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan.

Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan.

Journal: Scientific reports
Published: December 02, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026